Research Progress on the Application of Accelerated Repetitive
Transcranial Magnetic Stimulation

doi:10.3969/j.issn.2095-1396.2022.03.005

ACTA NEUROPHARMACOLOGICA ›› 2022, Vol. 12 ›› Issue (3): 23-.DOI: 10.3969/j.issn.2095-1396.2022.03.005

Previous Articles Next Articles

Research Progress on the Application of Accelerated Repetitive Transcranial Magnetic Stimulation

CUI Pei，SUN Yu-jiao，CHEN Jing-jing，ZHANG Xin-yu，DONG Yan-hong

1. Graduate School，Hebei North University，Zhangjiakou，075000，China 2. Department of Neurology，Hebei General Hospital，Shijiazhuang，050051，China 3. Graduate School，North China University of Science and Technology，Tangshan，063000，China

Online:2022-06-26 Published:2022-06-26

Abstract

Abstract:

Repetitive transcranial magnetic stimulation as a non-invasive brain stimulation technique，has been widely used in neuroscience research and the treatment of some neuropsychiatric diseases. Accelerated repetitive transcranial magnetic stimulation will increase the daily use frequency on the basis of conventional transcranial magnetic stimulation. This article will briefly review the intervention study of accelerated transcranial magnetic stimulation on common brain diseases and the comparison with conventional schemes.

Key words: accelerated repetitive transcranial magnetic stimulation, repetitive transcranial magnetic stimulation, Parkinson’s disease, depression, cognitive impairment, obsessivecompulsive disorder

CLC Number:

R969

CUI Pei, SUN Yu-jiao, CHEN Jing-jing, ZHANG Xin-yu, DONG Yan-hong. Research Progress on the Application of Accelerated Repetitive Transcranial Magnetic Stimulation[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(3): 23-.

[1]	JIANG Qin, WANG Yu-tong, HUANG Yu-qi, XU Zi-xuan, LU Ying-mei. Radiation-Induced Cognitive Impairment: Advances in Pathogenesis and Therapeutic Agents [J]. ACTA NEUROPHARMACOLOGICA, 2025, 15(3): 13-.
[2]	LI Xiao-dan, CHEN Ming, ZHENG Ying, WANG Zhi-jian, HUANG Ren-chun. Effects of Sertraline Combined with CCBT on Clinical Symptoms and Self-Care Abilities in Patients with Post-Schizophrenia Depression [J]. ACTA NEUROPHARMACOLOGICA, 2025, 15(1): 19-.
[3]	ZHANG Wei-jian, ZHAO Yun-hao, JIA Chong-ning, QIN Xue-mei, TIAN Jun-sheng. Research Progress on the Treatment of Depression with Chinese Medicine by Regulating Brain Sex Hormone Microenvironment Homeostasis [J]. ACTA NEUROPHARMACOLOGICA, 2025, 15(1): 25-.
[4]	ZHOU Xin-mei, ZHU Li-ping. Network Pharmacology Study of Sini SAN in the Treatment of Post-Stroke Depression [J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 19-.
[5]	LI Tian-tian, FU Xin, YE Jing-ying. Exploration of the Effect of Danggui-Shaoyao-Sanon Steroid Hormone Receptor in the Treatment of Diabetic Cognitive Impairment Based on Network Pharmacology and Molecular Docking [J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(3): 17-.
[6]	ZHANG Ran-ran, WU Zhi-gang. Research Progress of Neuroactive Steroid in the Treatment of Depression [J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(1): 49-.
[7]	HUANG He, LAN Yue-ying. Clinical Efficacy of Amsulpride Combined with Duloxetine in Treatment of Depression in Forced Detoxification Patients [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 43-.
[8]	GENG Xin-yu, SHANG Wen-xuan, LI Li-tao. Research on the Association Between Migraine and Cerebrovascular Disease [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 60-.
[9]	HUANG Yu-li, LI Xiang-bo, YUAN li, TENG Jin-liang. Research Progress on Clinical Efficacy and Adverse Reactions of Esketamine [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(4): 13-.
[10]	GAO Shan, GOU Yu-lan. Meta-Analysis of the Efficacy and Safety of Metformin in Improving Cognitive Function in Patients with Diabetes Mellitus [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 1-.
[11]	NIU Cong, WU Zhi-gang. Research Progress of Traditional Chinese Medicine in the Treatment of Depression [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 49-.
[12]	ZHAO Bo, YU Ai-mei, ZOU Yu-an. Research Progress of Cortical Spreading Depression [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(3): 28-.
[13]	DONG Lu-lu, WANG Lu-lu, CHEN Jing-hong, et al. Study on the Influencing Factors and Related Mechanisms of Dyskinesia in Parkinson’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(2): 53-.
[14]	PAN Yan-ting, ZHANG Xiao-jie, FAN Lei, LIU Xing-liang, YUE Bing-hong. Clinical Observation on Emotion, Cognition and Abnormal Sensation of Limbs in Parkinson’s Disease combinde with Type 2 Diabetes Mellitus [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(4): 1-.
[15]	SHEN Yuan, HUANG Shu-qi, ZHANG Kai. Effects of α-Synuclein on Endoplasmic Reticulum Stress and Apoptosis [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(2): 1-4.

Research Progress on the Application of Accelerated Repetitive Transcranial Magnetic Stimulation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics